EFFECT OF 6-HYDROXYDOPAMINE ON CARDIOTOXICITY OF OUABAIN IN GUINEA PIGS

EFFECT OF 6-HYDROXYDOPAMINE ON CARDIOTOXICITY OF OUABAIN IN GUINEA PIGS

Japan. J. Pharntacol. 24, 923 (1974) SHORT EFFECT OF 6-HYDROXYDOPAMINE OF Hideya SAITO, Toru OUABAIN OTANI, IN Isami ON GUINEA SHUDO COMM...

117KB Sizes 0 Downloads 24 Views

Japan.

J. Pharntacol.

24, 923 (1974)

SHORT

EFFECT

OF

6-HYDROXYDOPAMINE OF

Hideya

SAITO,

Toru

OUABAIN OTANI,

IN Isami

ON GUINEA SHUDO

COMMUNICATIONS

CARDIOTOXICITY PIGS

and Tsuneyoshi

TANABE

Dcparhncnt of Pharmacology, Hokkaido University School of Medicine, Sapporo, Japan Accepted September 12, 1974

Digitalized animals are highly susceptible to the arrhythmic effect of exogenous cate cholamines (1, 2). Large doses of these catecholamines produced an increase in the cate cholamine content in heart muscles and the catecholamine-saturated heart showed an increased responsivenessto the toxic effectof cardiac glycosidesin dogs and guinea pigs (3). Boyajy et al. also reported that ouabain toxicity was decreased in dogs which was pre treated with reserpine (4). However, nothing has been documented concerning the pos sible involvement of brain catecholamines in digitalis toxicity. The present experiments were designed to observe the role of central and peripheral catecholamines in the car diotoxicity of ouabain. Male and female guinea pigs weighing 400 to 600 g were pretreated with 6-hydro xydopamine in the following manner: One group of animals was administered 6-hydro xydopamine, 30 mg/kg i.p., twice a day and one week later 50 mg/kg i.p. twice a day (1st group). The other group of guinea pigs anesthetized with ether was subjected to injec tion of 6-hydroxydopamineinto the right lateral ventricle at a dose of 250 /tg/animal (2nd group). Experiments were then performed on catecholamine-reduced guinea pigs an esthetized with urethane. An external jugular vein was cannulated and continuous infu sion was performed at a rate of 3.2 Pg/min. ECG (lead 11)was recorded. The toxic dose of ouabain was expressed as the minimal dose which produced ventricular arrhythmias. The lethal dose (LD) of ouabain was considered that which produced cardiac art-est. The determination of catecholamine content in the brain cortex, brain stem, heart and adre nal glands was performed in another two groups of guinea pigs pretreated with 6-hydro xydopamine as aforementioned (5). As shown in Table 1, a marked increase in the toxic dose and lethal dose of ouabain was seen in the 1st group of guinea pigs. However, in the second group neither the toxic dose nor the lethal dose of ouabain revealed any change. It has already been shown that systemic administration of 6-hydroxydopamine in duced a selectivereduction of catecholamines in the peripheral tissues without any signifi cant alteration of the catecholamine content in the brain (6, 7, 8). Under these same ex perinmentalconditions, we also determined the catecholamine content of brain cortex,

SHORT TABLE 1. Changes

COMMUNICATIONS

in toxicity

xydopamine

of ouabain

Japan. J. Pharmacol. 24, 924 (1974)

induced

by

pretreatment

with

6-hydro

(6-OHDA)

TABLE2. Changes in the catecholamine content in the brain, heart and adrenal glands following administration of 6-hydroxydopamine (6-OHDA)(1)

brain

stem,

heart

pigs,

a marked

cant

reduction

and reduction

to the

2nd

served

in the

brain

heart

and

From appears not

the to

appear

glands.

group

of

cortex

and

glands

results

obtained

that

brain

was

guinea

adrenal

be closely

As shown

of norepinephrine

of catecholamines

regard

the

adrenal

associated

were

not

herein, with

catecholamines

was

observed

pigs,

brain

in Table seen

in the

heart.

in the

brain

and

a marked

stem,

2, in the

but

reduction significant

1st group

of guinea

However, adrenal

no

of norepinephrine changes

signifi

glands.

With was

in catecholamines

ob in

demonstrated. the reduction a decrease are

related

of catecholamine in ouabain to

the

content

toxicity.

toxicity

in the heart

However,

of ouabain.

it does

SHORT

COMMUNICATIONS

Japan. J. Pharmacol. 24, 925 (1974)

REFERENCES 1) TANABE,T., SAITO,H., OHARA, T., KANNO, M. AND IIDA, S.: Abstracts of the 3rd Interna tional Pharmacological Congress p. 501, S. Paulo, Brazil (1966); 2) SAITO, H., OTANI, T., SHUDO,I., MONMA,Y. AND TANABE,T.: Japan. J. Pharmacol. 23, Suppl. 7 (1973); 3) SAITO, H., OHARA, T., ISHIZAKI,T. AND TANABE,T.: Hokkaido Med. J. 46, 365 (1971) (in Japanese); 4) BOYAJY,L.D. AND NASH, C.B.: J. Pharmacol. exp. Ther. 148, 193 (1965); 5) SAITO, H., WORONKOW,S. AND MYERS, B.: Japan. Circ. J. 33, 620 (1969); 6) BRUS, R.: Archs int. Pharmacodyn. Ther. 201, 71 (1973); 7) HAEUSLER,G., GEROLD, M. AND THOENEN,H.: Arch. Pharmacol. 274, 211 (1972); 8) GAUTHIER,P., NADEAU,R. ANDCHAMPLAIN,J. DE.: Circulation Res. 31, 207 (1972)